Pregnancy and Renal Failure: The Case for Application of Dosage Guidelines

Drugs

Volumn 61, Issue 13, 2001, Pages 1901-1920

  Keller, Frieder ^a,d   Griesshammer, Martin ^a   Häussler, Ulla ^a   Paulus, Wolfgang ^b   Schwarz, Anke ^c  

^a UNIVERSITY OF ULM   (Germany)

^b Kloster Roggenburg   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

CHRONIC KIDNEY FAILURE; DOSE RESPONSE; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATION; RENAL REPLACEMENT THERAPY; REVIEW;

DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PHARMACEUTICAL PREPARATIONS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS; RENAL DIALYSIS;

EID: 0035237938     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200161130-00003     Document Type: Review

References (171)

1. Little BB. Pharmacokinetics during pregnancy: evidence-based maternal dose formulation. Obstet Gynecol 1999; 93: 858-68
2. Donati S, Baglio G, Spinelli A, et al. Drug use in pregnancy among Italian women. Eur J Clin Pharmacol 2000, 56: 323-8
3. Berkovitch M, Elbirt D, Addis A, et al. Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy [letter]. N Engl J Med 2000 Aug; 343: 445-6
4. Berkovitch M, Segel-Socher I, Greenberg R, et al, First trimester exposure to cefuroxime: a prospective cohort study. Br J Clin Pharmacol 2000, 50: 161-5
5. Lacroix I, Damasc-Michel C, Lapeyre-Mesire M, et al. Prescription of drugs during pregnancy in France, Lancet 2000; 356: 1735-6
6. Davison JM, Dunlop W. Renal hemodynamics and tubular function in normal human pregnancy. Kidney Int 1980; 18: 152-61
7. Locbstein R, Lalkin A, Addis A, et al. Pregnancy outcome after gestational exposure to ternadine: a multicenier, prospective controlled study. J Allerg Clin Immunol 1999 Nov; 104: 953-6
8. Doll DC, Ringenberg OS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989; 16: 337-46
9. Roubenoff R, Hoyt J, Petri M, et al. Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility. Semin Arthritis Rheum 1988 Nov; 18: 88-110
10. Armenti VT, Ahlswede KM, Ahlswede BA, et al. Variables affecting birthweight and graft survival in 197 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 1995 Feb 27; 59 (4): 476-9
11. Thomas AG, Burrows L, Knight R, et al. The effect of pregnancy on cyclosporine levels in renal allograft patients. Obstel Gynecol 1997 Dec; 90 (6): 916-9
12. Jarvis MA, Wu Pong S, Kniseley JS, et al. Alterations in methadone metabolism during late pregnancy. J Addict Dis 1999; 18 (4): 51-61
13. Riva E, Farina P, Tognoni G, et al. Pharmacokinetics of furosemide in gestosis of pregnancy. Euro J Clin Pharmacol 1978 Dec; 18: 361-6
14. Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 1996 Jul 25: 335 (4): 226-32
15. Bar J, Ben-Rafael Z, Padoa A. et al. Prediction of pregnancy outcome in subgroups of women with renal disease, Clin Nephrol 2000; 53: 437-44
16. Deubner H, Wagnild JP, Wener MH, et al. Glomerulonephritis with anti-glomerular basement membrane antibody during pregnancy: potential role of the placenta in amelioration of disease. Am J Kidney Dis 1995 Feb; 25 (2): 330-5
17. Dolkart LA, Tapia LA. Idiopathic rapidly progressive (crescentic) glomerulonephritis in pregnancy. Am J Perinatol 1996 May; 13(4): 199-201
18. Jungers P, Houillier P, Forget D, et al. Influence of pregnancy on the course of primary chronic glomerulonephritis. Lancet 1995 Oct 28; 346 (8983): 1122-4
19. Abe S. The influence of pregnancy on the long-term renal prognosis of IgA nephropathy. Clin Nephrol 1994 Feb; 41: 61-4
20. Lindheimer MD, Kaiz AI. Gestation in women with kidney disease; prognosis and management. Clin Obstet Gynaecol 1994; 8: 387-404
21. Hemmelder MH, de Zeeuw D, Fidler V, et al. Proteinuria: a risk factor for pregnancy-related renal function, dezline in primary glomerular disease? Am J Kidney Dis 1995 Jul; 26(1): 187-92
22. Kozlowska-Boszko B, Durlik M, Kuczynska-Sicinska J, et al. Predictor of transplanted kidney deterioration following pregnancy - daily urine protein loss or serum creatinine concentration? Ann Transplant 1996; 1 (4): 30-1
23. Holley JL, Bernardini J, Quadri KH, et al. Pregnancy outcomes in a prospective matched control study of pregnancy and renal disease. Clin Nephrol 1996 Feb; 45: 77-82
24. Chan WS, Okun N, Kjelltrand CM. Pregnancy in chronic dialysis: a review and analysis of the literature. Int J Artif Organs 1998 May; 21 (5): 259-68
25. Bagon JA, Vernaeve H, De Muylder X, et al. Pregnancy and dialysis. Am J Kidney Dis 1998 May; 31 (5): 756-65
26. Hou S, Firanek C. Management of the pregnant dialysis patient. Adv Ren Replace Ther 1998 Jan; 5(1): 24-30
27. Reister F, Reister B, Heyl W, et al. Dialysis and pregnancy - a case report and review of the literature. Ren Fail 1999 Sep; 21 (5): 533-9
28. Bar J, Fisch B, Wittenberg C, et al. Prednisone dosage and pregnancy outcome in renal allogrsft recipients. Nephrol Dial Transplant 1997 Apr; 12 (4): 760-3
29. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transplant 1997: 101-12
30. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 1999 Feb; 33 (2): 235-52
31. Furman B, Wiznitzer A, Hackmon R, et al. Multiple pregnancies in women after renal transplantation: case report that rises a management dilemma. Eur J Obstet Gynecol Reprod Biol. 1999 May; 84(1): 107-10
32. Saber LT, Duarte G, Costa JA, et al. Pregnancy and kidney transplantation: experience in a developing country. Am J Kidney Dis 1995 Mar; 25 (3): 465-70
33. Hussey MJ, Pombar X. Obstetric care for renal allograft recipients or for women treated with hemodialysis or peritoneal dialysis during pregnancy. Adv Ren Replace Ther 1998 Jan; 5(1): 3-13
34. Resch B, Mache CJ, Windhager T, et al. FK 506 and successful pregsancy in a patient after renal transplantation. Transplant Proc 1998 Feb; 30(1): 163-4
35. Sturgiss SN, Davison JM. Effect of pregnancy on the long-term function of renal allografts: an update. Am J Kidney Dis 1995 Jul; 26 (1): 54-6
36. Miller BW, Howard TK, Goss JA, et al. Renal transplantation one week after conception. Transplantation 1995 Dec 15; 60 (11): 1353-4
37. Czeizel AE. Drug use during pregnancy [Letter]. Lancet 2001; 357: 800
38. Hulton SA, Kaplan BS. Renal dysplasia associated with in utero exposure to gentamicin and corticosterois, Am J Med Genet 1995 Jul 31; 58 (1): 91-3
39. Robinson AJ, Ridgway GL. Concurrent gonococcal and chlamydial infection. Drugs 2000 Apr; 59: 801-13
40. Thakur CP, Singh RK, Hassan SM, et al. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Trans R Soc Trop Med Hyg 1999 May-Jun; 93 (3): 319-23
41. Miller JM, Martin DH. Treatment of chlamydia trachomatis infections in pregnant women. Drugs 2000 Sep; 60: 597-605
42. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000 May; 342: 1500-7
43. Hernandez-Diaz S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000 343: 1608-14
44. Jick SS. Pregnancy outcomes after maternal exposure to fluconazole. Pharmacotherapy 1999 Feb; 19 (2): 221-2
45. Sorensen HAT, Larsen H, Jensen ES, et al. Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women. J Antimicrob Chemother 1999; 44: 854-5
46. Sorensen HAT, Nielsen GL, OlesenC, et al. Risk of malformations and other outcomes in children exposed to fluconazole in utero. Br J Clin Pharmacol 1999 Aug; 48 (2): 234-8
47. Czeizel AE, Rockenbauer M. Sorensen HT, et al. A population-based case-control teratologic study of furazidine, a nitrofuran-derivative treatment during pregnancy. Clin Nephrol 2000; 53: 257-63
48. Bar-Oz B, Moretti ME, Bishai R, et al. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am J Obstet Gynecol 2000 Sep; 183: 617-20
49. Rosenblatt JE. Antiparasitic agents. Mayo Clin Proc 1999 Nov; 74 (11): 1161-75
50. Czeizel AE, Rockenbauer M, Sorensen HAT, et al. Teratogenic evaluation of oxacillin. Scand J Infect Dis 1999; 31: 311-2
51. Shulmann CE, Dorman EK. Dutts F, et al. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 1999; 353: 632-6
52. Anonymus. Quinolones and pregnancy: worrying animal findings, few clinical data. Prescr Int 1999 Feb 8; (39): 29-31
53. Anonymus. Recommendations for antiretrovirai therapy during pregnancy: prevention for the child; treatment for the mother Prescrire Int 1999 Feb 8; (39): 24-8
54. Hoffman RS. Thallium poisoning during preganancy: a case report and comprehensive literature review. Clin Toxicol 2000; 38: 767-75
55. Reyes MP. Ostrea EM, Cahinian AE, et al. Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant? Am J Obstet Gynecol 1989 Oct; 161: 977-81
56. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000 Oct; 356: 1423-30
57. Johnson MA, Moore KH, Yuen GJ, et al. Clinical pharmacokinetics of lamivudine. Clin Pharmacokinet 1999 Jan; 36 (1): 41-66
58. Mirochnick M, Clarke DF, Dorenbaum A. Nevirapine; pharmacokinetic considerations in children and pregnant women. Clin Pharmacokinet 2000; 39: 281-93
59. Honein MA, Paulozzi LJ, Cragan JD, et al. Evaluation of selected characteristics of pregnancy drug registries. Teratology 1999 Dec; 60 (6): 356-64
60. Wiktor SZ, Ekpini E, Karon JM. et al. Short -course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 1999 Mar; 353 (9155): 781-5
61. Rodman JH, Flynn PM, Robbins B. et al. Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficieny virus type I-infected women and newborn infants. J Infect Dis 1999 Dec; 180: 1844-50
62. Tomlinson AJ, Campbell J, Walker JJ, et al. Malignant primary hypertension in pregnancy treated with lisinopril. Ann Pharmacother. 2000 Feb; 34 (2): 180-2
63. Saji H, Yamanaka M, Hagiware A, et al. Losartan and fetal toxic effects [lette]. Lancet 2001; 357: 363
64. Tremlett MR, Kelly PJ, Parkins J. et al. Low-dose clonidine infusion during labor. BrJ Anaesth 1999 Aug 83 (2): 257-61
65. Suonio S, Saarikoski S, Tahvanainen K, et al. Acute effects of dihydralazine mesylale, furosemide, and metoprolol on maternal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 1986 Jul; 155: 122-5
66. Gudmundsson S, Gennser G. Marsal K. Effects of hydralazine on placental and renal circulation in pre-eclampsia. Acta Obstet Gynecol Scand 1995 Jul; 74 (6): 415-8
67. Lu JF, Nightingale CH. Magnesium sulfate in eclampsia and pre-eclanipsia. Clin Pharmacokinet 2000 Apr; 38: 306-14
68. Paulus WE. Pharmacotherapy in pregnancy. Ther Umsch 1999 Oct; 56 (10): 602-7
69. Armenti VT, Moritz MJ, Davison JM. Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf 1998 Sep; 19 (3): 219-32
70. Armenti VT, Moritz MJ, Davison JM. Medical management of the pregnant transplant recipient. Adv Ren Replace Ther 1998 Jan; 5 (1): 14-23
71. Koren G. Antimalarial drugs for rheumatoid disease during pregnancy. Can Fam Physician 1999 Dec; 45: 2869-70
72. Ghandour FZ, Knauss TC, Hricik DE. Immunosuppressive drugs in pregnancy. Adv Ren Replace Ther 1998 Jan; 5 (1): 31-7
73. Enns GM, Roeder E, Chan RT, et al. Apparcnt cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 1999 Sep 86 (3): 237-41
74. Parke A, West B. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol 1996 Oct; 23: 1715-8
75. Branch DW, Peaceman AM. Druzin M, et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 2000 Jan; 182 (1 Pt 1): 122-7
76. Prakash A, Jarvis B. Leflunomide: a review of its use in active rheumatoid arthritis. Drugs 1999 Dec; 58 (6): 1137-64
77. Pergola PE, Kancharla A, Riley DJ. Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil. tacrolimus, and prednisone. Transplantation 2001; 71: 994-7
78. Backos M, Rai R, Baxter N, et al. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999; 106: 102-7
79. Umesaki N, Ueda K, Tanaka T, et al. Favorable response to heparin in a pregnant woman with possible glomerular thrombosis as a complication of systemic lupus erythematosus and anti-phospholipid antibody syndrome. Osaka City Med J 1997 Jun; 43 (1): 89-94
80. Hunt BJ, Doughty HA, Majumdar G. et al. Thromboprophylaxis with low molecular weight heparin (fragmin) in high risk pregnancies. Thromb Haemost 1997; 77: 39-43
81. Chan WS, Ray JG. Low molecular weight heparin use during pregnancy: issues of safety and practicality. Obstet Gynecol Surv 1999 Oct; 54 (10): 649-54
82. Huhle G, Geberth M, Hoffmann U, et al. Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin. Gynecol Obstet-Invest 2000; 49: 67-9
83. Vitale N DeFeo M, DeSanto LS, Pollice A, et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999 May; 33 (6): 1637-41
84. Samren EB, van Duijn CM, Christiaens GC, et al. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999 Nov; 46: 739-46
85. Briggs GG, Freeman RK, Yaffe SJ, Drugs in pregnancy and lactation. 5th ed. Baltimore: Williams & Wilkins; 1999, (CD-ROM)
86. Mazzotta P, Magee LA. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs 2000 Apr; 59: 781-800
87. Wisner KL, Gelenberg AJ, Leonard H, et al. Pharmacologic treatment of depression during pregnancy. J Am Med Assoc 1999 Oct 282 (13): 1264-9
88. Diav-Citrin O, Okotore B, Lucarelli K, et al. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study. Am J Perinatol 1999; 16: 157-60
89. Ruigomez A, Rodriguez LAG, Cattaruzzi C, et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol 1999 Sep; 150 (5): 476-81
90. Sorensen, HT, Nielsen GL, Christensen K, et al. Birth outcome following maternal use of metoclopramide. Br J Clin Pharmacol 2000; 49: 264-8
91. Nielsen GL, Sorensen HT, Thulstrup AM, et al. The safety of proton pump inhibitors in pregnancy. Aliment Pharmacol Ther 1999 Aug; 13(8): 1085-9
92. Bishai R, Arbour L, Lyons C, et al. Intrauterine exposure to clomiphene and neonatal persistent hyperplastic primary vitreous. Teratology 1999 Sep; 60 (3): 143-5
93. Komhoff M, Wang JL, Cheng HF, et al. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 2000 Feb; 57 (2): 414-22
94. Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv 1998 Jul; 53 (7): 450-5
95. Nasu K, Yoshimatsu J, Anai T, et al. Low-dose dopamine in treating acute renal failure caused by preeclampsia. Gynecol Obstet Invest 1996; 42 (2): 140-1
96. Fagih B, Sami M. Safety of antiarrhythmics during pregnancy: case report and review of the literature. Can Cardiol 1999 Jan; 15 (1): 113-7
97. Wisner KL, Gelenberg AJ, Leonard H. et al. Pharmacologic treatment of depression during pregnancy. JAMA 1999 Oct 6; 282 (13): 1264-9
98. Greene MF. Oral hypoglycemic drugs for gestational diabetes. N Engl J Med 2000 Oct; 343: 1178-9
99. Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000, 343: 1134-8
100. Henck JW, Craft WR, Black A, et al. Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats. Toxicol Sci 1998 Jan; 41: 88-99
101. Stephan D, Welsch M, Chapatte D, et al. Deep venous thrombosis during pregnancy: long-term treatment with low molecular weight heparin [article in French]. Presse Med 1999 Nov 6; 28 (34): 1880
102. Letontourier P, How many daily insulin injections for the pregnant diabetic woman? Presse Med 1999 Dec; 28 (38): 2104-5
103. Griesshammer M, Bergmann L, Pearson T. Fertility, pregnancy and the management of myeloproliferative disorders. Baillieres Clin Haematol 1998 Dec; 11 (4): 859-74
104. Marcus WL. Lithium: a review of its pharmcokinetics, health effects, and toxicology. J Environ Pathol Toxicol Oncol 1994; 13: 73-9
105. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med 2000 Jul; 17: 507-11
106. Wang EC. Methadone treatment during pregnancy. J Obstet Gynecol Neonatal Nurs 1999 Nov-Dec; 28 (6): 615-22
107. Fischer G, Jagsch R, Eder H, et al. Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 1999 Feb; 94 (2): 231-9
108. Bernstein J, Werner AL, Verani R. Nonsteroidal anti-inflammatory drug fetal nephrotoxicity. Pediatr Dev Pathol 1998 Mar Apr: 1 (2): 153-6
109. Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Grave's hyperthyroidism. J Clin Endocrin Metabol 1997 Nov; 82: 3633-6
110. Thuermann PA, Steioff A. Drug treatment in pregnancy. Int J Clin Pharmacol Therap 2001; 39: 185-91
111. Cooper DS. Subclinical hypothyroidism. N Engl J Med 2001; 345: 260-5
112. Keller F, Offerman G, Lode H. Supplementary dose after hemodialysis. Nephron 1982; 30: 220-7
113. Olofsson P, Krutzen E, Nilsson-Ehle P. Iohexol clearance for assessment of glomerular filtration rate in diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol 1996 Jan; 64: 63-7
114. Keller F, Giehl M, Frankewitsch T, et al. Pharmacokinetics and drug dosage adjustment to renal impairment. Nephrol Dial Transplant 1995; 10: 1516-20
115. Quadri KH, Bernardini J, Greenberg A, et al. Assessment of renal function during pregnancy using random urine protein to creatinine ratio and Cockeroft-Gault formula. Am J Kidney Dis 1994 Sep; 24: 416-20
116. Wang Y, Livingston E, Patil S, et al. Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus-infectd pregnant women and their neonates: an AIDS clinical trials group study. J Infect Dis 1999 Nov; 180: 1536-41
117. Dettli L. Drug dosage in renal disease. Clin Pharmacokinet 1976; 1: 126-34
118. Kunin CM. A guide to the use of antibiotics in patients with renal disease. Ann Intern Med 1967; 67: 151-8
119. Holford NH. Target concentration intervention: beyond Y2K. Br J Clin Pharmacol 1999 Jul; 48 (1): 9-13
120. Keller F, Frankewitsch T, Zellner D, et al. Standardized structure and modular design of a pharmacokinetic database. Comput-Methods-Programs-Biomed. 1998 Feb; 55 (2): 107-15
121. Banyai M, Thalhammer F, El-Manyawi I, et al. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hours dosing interval. Clin Pharmacol Ther 2000 Apr; 67: 368-72
122. Kon SP, Kwan JT, Raftery MJ, Reversible renal failure due to the antiphospholipid antibody syndrome, pre-eclampsia and renal thrombotic microangiopathy. Clin Nephrol 1995 Oct; 44 (4): 271-3
123. Solling J, Paulsen SM. Recurrent hemolytic aremic syndrome in a renal transplant patient during pregnancy. Scand J Urol Nephrol 1995 Dec; 29 (4): 507-10
124. Ribeiro FM, Rocha E, Maccariello E, et al. Early gestational hemolytic uremic syndrome: case report and review of liter ature. Ren Fail 1997 May; 19 (3): 475-9
125. Martinez-Roman S, Gratacos E, Torne A, et al, Successful pregnancy in a patient with hemolytic-uremic syndrome during the second trimester of pregnancy. J Reprod Med 1996 Mar: 41; 211-4
126. Ruiz-Irastorza G, Lima F, Alves J, et al. Increased rate of lupus flare during pregnancy and the puerperium; a prospective study of 78 pregnancies. Br J Rheumatol 1996 Feb; 35 (2): 133-8
127. Makhseed M, Raghupathy R, Azizieh F, et al. Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions. Hum Reprod 2000 Sep; 15: 2011-7
128. Ostensen M. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann N Y Acad Sci 1999 Jun; 22: 111-43
129. Dorner T, Feist E, Pruss A,et al. Significance of autoantibodies in neonatal lupus erythematosus. Int Arch Allergy Immunol 2000 Sep; 123 (1): 58-66
130. Azevedo LS, Romao Jr JE, Malheiros D, et al. Renal transplantation in systemic lupus erythematosus. A case control study of 45 patients. Nephrol Dial Transplant 1998 Nov: 13 (11): 2894-8
131. Meng C, Lockshin M. Pregnancy in lupus. Curr Opin Rheumatol 1999 Sep; 11 (5): 348-51
132. Boletis JN, Ioannidis JP, Boki KA, et al. Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis. Lancet 1999 Aug 14; 354 (9178): 569-70
133. Levy Y, Sherer Y, Ahmed A, et al. A study of 20 SLE patients with intravenous immunoglobulin - clinical and serologic response. Lupus 1999; 8 (9): 705-12
134. Yu Z, Lennon VA. Mechanism of intravasous immune globuline therapy in antibody - mediated autoimmune diseases. N Engl J Med 1999; 340: 227-8
135. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291: 484-6
136. Takeshita Y, Turumi Y, Touma S, et al. Successful delivery in a pregnant woman with lupus anticoagulatn positive systemic lupus erythematosus treated with double filtration plasmapheresis. Therap Apheresis 2001; 5: 22-4
137. Reece BA, Leguizamon G, Homko C. Pregnancy performance and outcomes associated with diabetic nephropathy. Am J Perinatol 1998 Jul; 15 (7): 413-21
138. Piacquadio K, Hollingsworth DR, Murphy H. Effects of inutero exposure to oral hypoglycaemic drugs. Lancet 1991: 338: 866-9
139. Harrower AD. Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency. Clin Pharmacokinet 1996 Aug: 111-119
140. Hamai Y, Fujii T, Nishina H, et al. Differential clinical courses of pregnancies complicated by diabetes insipidus which does, or does not, pre-date the pregnancy. Hum Reprod 1997 Aug; 12 (8): 1816-8
141. Briet JW. Diabetes insipidus, Sheehan's syndrome and pregnancy. Eur J Obstet Gynecol Reprod Biol 1998 Apr; 77 (2): 201-3
142. Jin-no Y, Kamiya Y, Okada M, et al. Pregnant woman with transient diabetes insipidus resistant to 1-desamino-8-D-arginine vasopressin. Endocrinol J 1998 Oct; 45 (5): 693-6
143. Hanson RS, Powrie RO, Larson L. Diabetes insipidus in pregnancy: a treatable cause of oligohydramnios. Obstet Gynecol 1997 May; 89 (5 Pt 2): 816-7
144. Smith LG, Kirshon B, Cotton DB. Indomethacin treatment for polyhydramnios and subsequent infantile nephrogenic diabetes insipidus. Am J Obstet Gynecol 1990 Jul; 163: 98-9
145. Ulrich M, Kristoffersen K, Rolschau J, et al. The influence of folic acid supplement on the outcome of pregnancies in the country of Funen in Demark. Part II. Congenital anomalies, a randomised study, Eur J Obstet Gynecol Reprod Biol 1999 Dec; 87 (2): 111-3
146. Nulman I, Laslo D, Koren G. Treatment of epilepsy in pregnancy. Drugs 1999 Apr; 57 (4): 535-44
147. McGowan JP, Shah SS. Reviews. Revention of perinatal HIV transmission during pregnancy. J Antimicrob Chemother 2000; 46: 657-68
148. al-Alaiyan S, Seshia MM, Casiro OG. Neurodevelopmental outcome of infants exposed to indomethacin antenatally. J Perinatol Med 1996; 24 (4): 405-11
149. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med 2001; 344: 38-47
150. Achtari C, Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy Am J Obstet Gynecol 2000 Aug; 183: 511-2
151. Salooja N. Szydlo RM, Socie G, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet. 2001 Jul; 358 (9278): 271-6
152. Olesen C, Steffensen FH, Nielsen GL. et al. Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol 1999 Apr; 55 (2): 139-41
153. Bar-Oz B, Moretti ME, Mareels G, et al. Reporting bias in retrospective ascertainment of drug-induced embryopathy. Lancet 1999 Nov 13; 354 (9191): 1700-1
154. McGowan JP, Crane M, Wiznia AA, et al. Combination antiretrovirai therapy in human immunodeficiency virus-infected pregnant women. Obstet Gynecol 1999 Nov; 94 (5 Pt 1): 641-6
155. Olyaei AJ, De Mattos AM, Bennett WM. A practical guide to the management of hypertension in renal transplant recipients. Drugs 1999; 58: 1011-27
156. Von Dadelszen P, Ornstein MP. Bull SB, et al. Fall in mean pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000; 355: 87-92
157. Anonymus. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995. MMWR Morb Mortal Wkly Rep 1997; Mar 21; 46 (11): 240-2
158. Satchell S, Moppett J, Quinn M, et al Pregnancy, tacrolimus, and renal transplantation: survival of a 358-g baby [letter]. Nephrol Dial Transplant 2000: 15: 2065-6
159. Yunis KA, Bitar FF, Hayek P, et al. Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids. Am J Perinatol 1999 16 (1): 17-21
160. Carmichael SL, Shaw GM. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 1999 Sep; 86(3): 242-4
161. Biesenbach G. Zazgornik J, Kaiser W, et al. Cyclosporin requirement during pregnancy in renal transplant recipients. Nephrol Dial Transplant 1989, 4: 667-9
162. Smit JW, Huisman MT, van Tellingen O, et al. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 1999 Nov; 104 (10): 1441-7
163. Lo Giudice P, Dubourg L, Hadj-Aissa A, et al. Renal function of children exposed to cyclosporin in utero. Nephrol Dial Transplant 2000; 15: 1575-9
164. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000 Jan 24: 160 (2): 191-6
165. Crowther MA, Spitzer K, Julian J, et al. Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients; a retrospective study. Thromb Res 2000 Apr; 98: 133-8
166. Meschengieser SS, Fondevila CG, Santarelli MT. et al. Anticoagulation in pregnant women with mechanical heart valve prostheses Heart 1999 Jul: 82 (1): 23-6
167. Thorp M, Pulliam J. Use of recombinant erythropoietin in a pregnant renal transplant recipient. Am J Nephrol 1998; 18 (5): 448-51
168. Al Shohaib S. Erythropoietin therapy in a pregnant post-renal transplant patient. Nephron 1999 Jan; 81 (1): 81-3
169. Maruyama H, Shimada H, Obayashi H, et al. Requiring higher doses of erythropoietin suggests pregnancy in hemodialysis patients. Nephron 1998 Aug; 79 (4): 413-9
170. Oei SG, Mol BW, deKleine JMJ, et al. Nifedipine varsus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstet Gynecol Scand 1999 Oct: 78 (9): 783-8
171. Braden GL, von Oeyen PT, Germain MJ, et al. Ritodrine- and terbutaline-induced hypokalemia in preterm labor: mechanisms and consequences. Kidney Int 1997 Jun: 51 (6): 1867-75